Left ventricular assist device is a mechanical pump that is used for the patients who are suffering from heart failure disease. The left ventricular assist device is surgically implanted inside the patient’s chest. The left ventricular assist device works with the heart to pump more blood, and improves other organ function by improving blood flow to the brain, kidney, liver, and other body organs. The device continuously takes blood from the left ventricle and passes it to the aorta. Doctors implant this device for treatment of severe heart conditions such as chronic cardiac function disorders, and heart failure.

The global Left Ventricular Assist Device market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Left Ventricular Assist Device volume and value at global level, regional level and company level. From a global perspective, this report represents overall Left Ventricular Assist Device market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Left Ventricular Assist Device in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Left Ventricular Assist Device manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abiomed
Heart Ware International
Thoratec Corporation
Berlin Heart
Apaxis
Jarvik Heart
CorWave
ReliantHeart
Evaheart,

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Transcutaneous Ventricular Assist Device
Implantable Ventricular Assist Device

Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiology Centers